pyrazinamide has been researched along with Anemia, Hemolytic in 1 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Siribaddana, SH | 1 |
| Wijesundera, A | 1 |
1 other study available for pyrazinamide and Anemia, Hemolytic
| Article | Year |
|---|---|
Autoimmune haemolytic anaemia responding to anti-tuberculous treatment.
Topics: Adult; Anemia, Hemolytic; Antitubercular Agents; Autoimmune Diseases; Biopsy; Drug Therapy, Combinat | 1997 |